Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
gptkb:Kymera_Therapeutics
|
| gptkbp:firstClinicalTrial |
2022
|
| https://www.w3.org/2000/01/rdf-schema#label |
KSQ-001
|
| gptkbp:indication |
solid tumors
|
| gptkbp:mechanismOfAction |
USP1 inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:USP1
|
| gptkbp:bfsParent |
gptkb:KSQ-001EX
|
| gptkbp:bfsLayer |
6
|